Europe NGS Automation Market (2025-2032)
The Europe NGS Automation Market is projected to reach $380.4 million by 2032, at a CAGR of 13.4% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 120
- Format
- PDF + Excel
- Report ID
- MRHC - 104961
- Base year
- 2024
- 2032 · FORECAST
- $380.4M
- 2032
- $380.4M
- CAGR 2025–2032
- 13.4%
2024 baseline · 2025–2032 forecast at 13.4% CAGR · hover a bar for the value
Key highlights
The Workstation/Robotic Platform Segment to Dominate the Market in 2025
The Drug Discovery Segment to Dominate the Europe NGS Automation Market in 2025
The Whole Genome Sequencing Segment to Dominate the Europe NGS Automation Market in 2025
The Pharmaceutical and Biotechnology Companies Segment to Dominate the Europe NGS Automation Market in 2025
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 380.4 million |
| CAGR (2025–2032) | 13.4% |
| Format | PDF, Excel & Cloud Portal · 120 pages |
| Segments Covered | By Product: Workstation/Robotic Platform, Reagents & Consumables · By Application: Drug Discovery, Clinical Diagnostics Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics · By Sequencing Type: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing, Other Sequencing Types · By End User: Hospitals & Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Others End Users |
| Countries Covered | Europe (RoE) |
| Key Companies | Agilent Technologies, Inc., Danaher Corporation, Eppendorf AG, PerkinElmer, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG |
Report overview
Segments covered: product, application, sequencing type, end user. Regions: Europe.
Next-generation sequencing (NGS) includes sample pre-processing, library preparation, sequencing, and bioinformatics. The library preparation step is critical in NGS workflow; however, it is still time-consuming and repetitive despite ongoing technical advancements in high-throughput sequencing. The library preparation step has numerous repetitive steps that require small volumes to be pipetted with high precision. This process makes it highly prone to manual errors, compromising the entire NGS process. Automation of library preparation can increase efficiency, generate more consistent results, and increase lab efficiency. NGS automation also helps maintain turnaround times and increase sample throughput.
The main factors driving the NGS automation market are the increasing demand for automation in NGS workflow, the rising incidences of cancer, and the increasing R&D investments and healthcare expenditure. Furthermore, the increasing applications of next-generation sequencing and the rising number of collaborations between companies to develop library preparation protocols are expected to provide significant growth opportunities for this market.
However, the high cost of automation workstations is expected to restrain the growth of this market to a notable extent. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the requirement of high-skilled personnel for operating automation software are the major challenges to the growth of this market.
Report infographic
Market dynamics
1 factors across 1 forceRising Prevalence of Cancer to Drive Market Growth
Cancer is a prominent cause of death and a major obstacle to improving life expectancy in every country worldwide. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women succumb to the disease. Europe also faces a similar scenario of rising cancer prevalence. According to IARC, the number of new cancer cases in Europe is estimated to increase from 4.39 million in 2020 to 4.91 million by 2032.
NGS allows comprehensive profiling of a patient's tumor DNA, which guides the development of personalized treatment plans. As the number of cancer cases continues to rise, there is a growing need for NGS automation solutions to efficiently process and analyze the vast amount of genetic data generated in cancer diagnostics and research. Additionally, the rising cancer prevalence creates a high demand for new cancer drugs. Therefore, pharmaceutical and biotechnology companies require efficient and high-throughput NGS automation solutions for research and development.
Thus, the rising prevalence of cancer and increasing efforts to develop targeted treatment approaches are expected to drive the NGS automation market in Europe.
Table of contents
12 chapters · 85 sections · 120 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Workstation/Robotic Platform | — |
| By Application | Drug Discovery | — |
| By Sequencing Type | Whole Genome Sequencing | — |
| By End User | Pharmaceutical and Biotechnology Companies | — |
By Product
- The Workstation/Robotic Platform Segment to Dominate the Market in 2025
- The workstations/robotic platforms segment is expected to account for the larger share of the NGS automation market in Europe.
- The large market share of this segment is attributed to factors such as the increasing pharmaceutical R&D expenditure and the rising demand for automation of NGS library preparation due to its benefits, such as increased efficiency and the ability to generate consistent and reproducible results.
By Application
- The Drug Discovery Segment to Dominate the Europe NGS Automation Market in 2025
- The drug discovery segment is expected to account for the largest share of the NGS automation market in Europe.
- The large market share of this segment is attributed to the increased use of NGS technologies in drug discovery and the potential of NGS to cut down drug development costs and reduce the duration of drug discoveries.
- Next-generation sequencing has ushered in a new era of gene-based drug development by enabling high-throughput analysis of genotype-phenotype relationships in human populations, boosting the demand for NGS automation.
By Sequencing Type
- The whole genome sequencing segment is expected to account for the largest share of the NGS automation market in Europe.
- The large market share of this segment is attributed to the rising need to lower the per-sample cost of whole-genome sequencing by automating the NGS library preparation.
- Library preparation activities such as DNA extraction, quantification, fragmentation, normalization, purification, and quality control are labor-intensive and slow down the generation of sequencing data; hence, there is a rising demand for the adoption of NGS automation solutions.
By End User
- The Pharmaceutical and Biotechnology Companies Segment to Dominate the Europe NGS Automation Market in 2025
- Europe NGS Automation market is segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, and other end users.
- The pharmaceutical & biotechnology companies segment is expected to account for the largest share of the NGS automation market in Europe.
- The large share of this segment is attributed to the increasing pharmaceutical and biotechnology R&D expenditure, growing adoption of NGS in drug discovery and development, and increased government funding for research activities.
- Furthermore, the increasing investments by pharmaceutical and biotechnology companies in advanced NGS automation systems are one of the major factors driving the growth of this segment.
Competitive landscape
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf AG
- PerkinElmer, Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
Frequently asked questions
The Europe NGS automation market report covers the market sizes & forecasts based on product, application, sequencing type, end user, and geography. The NGS automation market studied in this report involves the value analysis of various segments and subsegments of Europe NGS automation at the regional and country levels.
Cite this report
Meticulous Research. (2025). Europe NGS Automation Market - Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104961). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/europe-ngs-automation-market-5644